DifGen Pharmaceuticals expands complex generics footprint with fluorometholone ophthalmic suspension approval
DifGen Pharmaceuticals secures rare FDA approval for fluorometholone ophthalmic suspension. Find out why this complex generic matters for ophthalmology markets.